Key points
- Lenire combines sound through headphones with mild tongue stimulation.
- It received FDA De Novo authorization in 2023.
- Studies report improvement for many users, but the largest published trial had no sham-device group.
- It takes daily sessions over several weeks.
Lenire is one of the newest options for tinnitus, and one of the most asked about. Here's a balanced look, written by an audiologist who provides it.
How it works
Lenire is a form of bimodal neuromodulation, which means stimulating two senses at once. You wear headphones that play a sequence of sounds while a small mouthpiece called the Tonguetip gives gentle electrical stimulation to the tongue. The idea is that pairing the two encourages the brain to change how it processes tinnitus.
The evidence
In a large randomized study, adults used the device daily for 12 weeks, and many reported meaningful improvement on standard tinnitus questionnaires.[2] Two things are worth knowing. First, that study compared different device settings and did not include a sham-device group, so it can't fully separate the device's effect from expectation and attention. Second, the trials were sponsored by the manufacturer.
Lenire received FDA De Novo authorization in March 2023, supported by a further trial comparing it with sound therapy alone.[1] De Novo is the pathway for new types of low- to moderate-risk devices. It doesn't mean the device has been shown to work for everyone.
Lenire is a reasonable option for some people. It is not a cure, and it isn't the right first step for everyone.
Who it may suit
Lenire is intended for adults whose tinnitus has at least a moderate impact on daily life, after an assessment by a trained clinician.[1] It tends to suit people who can commit to daily sessions and attend follow-up visits.
What it involves
- A full hearing and tinnitus evaluation first
- Daily sessions at home, usually two 30-minute sessions a day, as set by your audiologist
- Follow-up visits to adjust settings and recheck questionnaire scores
- A conversation about cost, since coverage varies
How it fits with other care
The tinnitus guideline predates Lenire and recommends education, counseling and CBT, plus hearing aids where there is hearing loss.[3] Lenire can sit alongside those approaches; it doesn't replace them.
When to get help
If you're considering Lenire, start with a full tinnitus evaluation so you can compare it with other options. Pulsing or one-sided tinnitus needs a physician's evaluation first.
Sources
- Neuromod Devices. FDA grants Lenire tinnitus treatment device De Novo approval. Company announcement, March 2023. Read the source (opens in a new tab)
- Conlon B, Langguth B, Hamilton C, et al. Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study. Sci Transl Med. 2020;12(564):eabb2830. Read the source (opens in a new tab)
- Tunkel DE, Bauer CA, Sun GH, et al. Clinical practice guideline: tinnitus. Otolaryngol Head Neck Surg. 2014;151(2 Suppl):S1-S40. Read the source (opens in a new tab)
This article is general education for adults and is not a substitute for personal advice from a clinician who has examined you. In an emergency, call 911.